Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Capecitabine 500 mg Tablet NDC 00378-2512-78 28 days supply and 21 days supply Recalled by Kroger Specialty Pharmacy, Inc. Due to Lack of Processing Controls.
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Kroger Specialty Pharmacy, Inc. directly.
Affected Products
Capecitabine 500 mg Tablet NDC 00378-2512-78 28 days supply and 21 days supply
Quantity: Unknown
Why Was This Recalled?
Lack of Processing Controls.
Where Was This Sold?
This product was distributed to 5 states: AR, FL, IL, LA, MS
About Kroger Specialty Pharmacy, Inc.
Kroger Specialty Pharmacy, Inc. has 67 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report